经订约方一致同意，现有商标许可协议将于2025年12月31日终止。公司与同仁堂集团公司于2025年11月 28日订立新商标许可框架协议。据此，同仁堂集团公司同意允许集团使用同仁堂集团公司的「同仁堂」 字号及部分商标，期限自2026年1月1日至2027年12月31日止。 格隆汇11月28日丨同仁堂国药(03613.HK)公告，内容有关(其中包括)与同仁堂集团公司于2013年4月15日 订立现有商标许可协议，据此，公司无须就使用同仁堂集团公司商标缴付任何费用或收费。 ...

同仁堂科技(01666)发布公告，于2025年11月28日，非执行董事陈飞先生由于工作变动申请辞任非执行 董事。陈飞先生的辞任将自公司适时召开的股东大会上选出新任非执行董事起生效。于2025年11月28 日，董事会建议委任杜欣女士为非执行董事。根据公司公司章程，该委任须待股东于股东大会上批准后 方可落实。 ...

Core Viewpoint - Tong Ren Tang Technologies (600085) announced the resignation of non-executive director Mr. Chen Fei due to job changes, effective upon the appointment of a new non-executive director at the upcoming shareholders' meeting [1] Group 1 - Mr. Chen Fei's resignation will take effect after the election of a new non-executive director at the shareholders' meeting [1] - The board has proposed the appointment of Ms. Du Xin as the new non-executive director, pending approval at the shareholders' meeting [1] - The appointment of Ms. Du Xin must comply with the company's articles of association and requires shareholder approval to be finalized [1]

Core Viewpoint - Tong Ren Tang Technologies (01666.HK) announced the resignation of non-executive director Chen Fei due to job changes, effective upon the election of a new non-executive director at the upcoming shareholders' meeting [1] Group 1 - Chen Fei's resignation will take effect after the shareholders' meeting where a new non-executive director is elected [1] - The board has proposed the appointment of Du Xin as a non-executive director, pending approval at the shareholders' meeting [1]

Core Insights - The "Family Medicine Cabinet" initiative by Beijing Evening News has been promoting scientific medication use for 14 years, aiming to enhance public health awareness and literacy [1][2] - The 2025 Family Medicine series is currently active, with plans to launch a "Family Medicine Box" program targeting various demographics through personalized medication advice [1][4] Group 1: Initiative Overview - The initiative has partnered with over 400 chain pharmacies in Beijing, including well-known brands, to engage the public in health discussions and medication inquiries [2][3] - Annual special editions are published based on industry trends and public voting, resulting in the "Top Ten Health Brands and Recommended Family Medicines" list, covering various medication categories [2] Group 2: Community Engagement - The initiative collaborates with the "Party Newspaper into Community" series to conduct health knowledge lectures and consultations in over a hundred communities in Beijing [3] - The "Family Medicine Box" program will expand its reach by providing free medicine and health education, enhancing community engagement [4] Group 3: Multi-Channel Approach - The program will utilize both online and offline channels to maximize participation and accessibility, ensuring the "Family Medicine" concept becomes ingrained in daily life [5] - Beijing Tongrentang and Dingdang Kuaiyao are key partners, emphasizing the importance of family medicine in health management, especially for vulnerable groups [6][7] Group 4: Supply Chain and Service Enhancements - Beijing Tongrentang has proactively stocked essential medications ahead of the flu season, ensuring availability and timely service [6] - Dingdang Kuaiyao has implemented a smart supply chain system to meet evolving health demands, providing 24/7 health services and consultations [7]

Core Insights - The Beijing Tongrentang Group has officially opened the second community health service center in Huaxiang Street, Fengtai District, as part of a key livelihood project by the local government [1] Group 1: Project Overview - The health service center is characterized by its "famous doctors + famous medicines" approach, aiming to enhance basic medical services in the Huaxiang area [1] - The center is designed to provide a comprehensive service system that includes "general coverage + specialized collaboration + traditional Chinese medicine features" [1] Group 2: Community Impact - The new center is expected to facilitate medical access for tens of thousands of residents in the district, injecting new momentum into grassroots health security [1]

Core Points - The Beijing Tongrentang's second community health service center in Huaxiang Street officially commenced operations, enhancing local healthcare services for thousands of residents [1][2] - The center features a comprehensive service system that integrates general and specialized care with traditional Chinese medicine, aiming to provide convenient and efficient medical services [2][3] - The center's unique "famous doctors + famous medicines" dual assurance system leverages high-quality traditional Chinese medicine and expert practitioners to ensure effective healthcare delivery [3][4] Summary by Sections Service Features - The health service center includes 14 clinical departments and various medical technology support services, offering a wide range of treatments and preventive care [2][3] - Services include traditional Chinese medicine techniques such as acupuncture and cupping, alongside modern medical practices, ensuring comprehensive healthcare coverage [2][3] Community Impact - The center is positioned as a reliable "health station" for residents, providing accessible healthcare and promoting public health in the Huaxiang area [3][4] - The opening of the center is seen as a significant step towards enhancing public health capabilities in the region, contributing to the "Healthy Fengtai" initiative [2][4] Strategic Development - Beijing Tongrentang is expanding its community healthcare network, having already established services in multiple districts, serving nearly 300,000 residents [4][5] - The company is committed to integrating online and offline healthcare services, enhancing accessibility through digital platforms [4][5] Tailored Services - The center offers customized services for different demographics, including elderly care packages and home visits for those with mobility issues, ensuring comprehensive support for all community members [5] - The focus on "Chinese medicine +" highlights the company's commitment to providing culturally relevant healthcare solutions [5]

Core Viewpoint - Beijing Tongrentang Co., Ltd. is implementing a core strategy of "inheriting essence and innovating with integrity," focusing on cultural empowerment, digital intelligence, professional collaboration, and quality foundation in its marketing approach [1][2]. Group 1: Cultural Empowerment - The company is breaking traditional cultural dissemination models by creating a "Traditional Chinese Medicine Health Culture IP" centered around the "Qingxin Jiannao Huoluo Exercise," which aims to establish a closed-loop operation of "cultural awareness - user education - product scenario binding" [4]. - This initiative targets the elderly population, providing practical "preventive healthcare" solutions through a platform that covers 14 core cities and nearly 2 million elderly families [4]. - Collaborations with organizations like the China Marriage and Family Research Association and the China Elderly Sports Association enhance community engagement and service offerings [4]. Group 2: Digital Intelligence - The company is accelerating its digital transformation to enhance operational efficiency and user service, establishing a "data-driven, intelligent collaboration" marketing model [6]. - A digital marketing decision-making platform has been developed to collect data across various dimensions, enabling real-time market trend analysis and dynamic optimization of marketing strategies [6]. - The launch of an AI-driven health service platform in collaboration with Xiaomi aims to lower barriers for users seeking TCM services and effectively reach younger consumers [7]. Group 3: Professional Collaboration - The company is focusing on grassroots medical services as a key area for market expansion, creating a collaborative ecosystem among enterprises, medical institutions, and grassroots practitioners [8]. - The "Strong Foundation Cultivation of Chinese and Western Medicine" project aims to ensure high-quality training for practitioners through a structured selection and training process [8][9]. Group 4: Quality Foundation - Quality is emphasized as the lifeline of the brand, with a comprehensive supply chain quality control system established from sourcing to production and end-user traceability [10]. - The company adheres to strict standards in sourcing, particularly with its Jilin ginseng, which has received multiple organic certifications, ensuring high-quality products [10]. - A traceability system allows consumers to access detailed information about the entire process of herbal medicine, reinforcing trust in the brand's quality [10].

根据天津的药品清单，共涉及886个药品，大部分每日费用与同品种最小每日费用相比在10倍以内，但 也有多款药品价格相比超千倍。比如，药都制药集团的逍遥丸每日费用为2129.40元，同品种最小每日 费用则为0.70元，相比为3042倍；药都制药集团的补中益气丸每日费用为3807.00元，同品种最小每日费 用为1.50元，相比为2538倍；此外，津药达仁堂集团乐仁堂制药厂的人参归脾丸、同仁堂制药厂的明目 地黄丸价格差异均在千倍以上。 为引导企业规范价格行为，国家医保局将日均治疗费用价差大于10倍及以上，且挂网价高于100元的疑 似高价中成药线索分发给各地。专项治理行动由此展开。 11月下旬，安徽、天津、山西、辽宁等多地又密集发布新一批价格风险线索，要求相关企业认真开展医 药价格自查，主动规范价格行为，将价格调整至合理水平。 梳理各地通知可以发现，部分地区涉及的药品清单并未公开，比如辽宁只有企业可以在招采系统中可以 查看；部分地区涉及的药品清单虽然已经公开，但并未发布药品具体价格，如山西给出了具体药品，并 公布了合理水平的药价，但没有药品目前的价格；也有部分地区直接公布了产品价格，比如天津。 【#有中成药最高价差超3 ...

最高价差超3000倍 记者丨闫硕 编辑丨季媛媛 近日，多地密集发布中成药异常价格风险线索，中成药价格治理向纵深发展。 11月25日，安徽发布《关于中成药医药价格核查线索通报处置的通知》，要求涉及的中成药企业于2025年11月25日至11月28日 登录省药品交易系统自主降价。除安徽外，山西、山东、内蒙古、天津、辽宁等多地近日也发布类似通知。 这项覆盖多地的价格治理工作始于今年7月。彼时，业内流传一份名为《医药价格风险线索通报（第一批）》的文件，这是国家 医保局为引导企业规范价格行为而发布的。随后，各地积极响应，开展中成药异常价格风险线索处置工作，目前多地基本实现 常态化治理。 随着此项工作深入推进，部分省市的信息公开力度不断加大，价格差异引发广泛关注。以天津为例，在今年9月发布的治理清单 中尚未公布涉及药品的每日费用，但在11月21日发布的清单中进行了公布，部分药品每日费用与同品种最小每日费用相比在千 倍以上，最高达3042倍，相差较大。 一般而言，由于同一名称的中成药成分可能不同、不同企业的质量标准可能有差异等因素，同一种中成药价格会有所差异，但 如果中成药名称、选材、剂型、质量标准均相同，却出现十几倍甚至数 ...